Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Sonoma Pharmaceuticals Inc (SNOA)

3.85 0.13 (3.49%)

05-23 16:00

Open:

3.74

Pre. Close:

3.72

High:

3.9052

Low:

3.7

Volume:

59,092

Market Cap:

18M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.914 - 3.93

3.93 - 3.943

Low:

3.658 - 3.677

3.677 - 3.693

Close:

3.817 - 3.848

3.848 - 3.875

Technical analysis  (as of: 2018-05-23 4:31:55 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 4.67     One year: 5.46

Support:

Support1: 3.78    Support2: 3.65

Resistance:

Resistance1: 4.00    Resistance2: 4.67

Pivot:

3.79

Moving Averages:

MA(5): 3.81     MA(20): 3.79

MA(100): 4.30     MA(250): 5.10

MACD:

MACD(12,26): -0.02     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 49.17     %D(3): 49.89

RSI:

RSI(14): 51.52

52-Week:

High: 7.75  Low: 3.5  Change(%): -43.0

Average Vol(K):

3-Month: 14533  10-Days 3447

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
SNOA has closed below upper band by 19.0%. Bollinger Bands are 75% narrower than normal. The narrow width of the bands suggests low volatility as compared to SNOA's normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-05T12:43:55-04:00
Midday Gainers / Losers (4/5/2018)

2018-04-05T09:14:19-04:00
Premarket Gainers as of 9:05 am (1/18/2018)

2018-04-05T07:11:43-04:00
FDA clears Sonoma Pharma's antimicrobial post-therapy gel

2018-03-02T08:36:05-05:00
Sonoma Pharmaceuticals prices common stock offering at $3.50

2018-02-09T08:00:00-05:00
Your Daily Pharma Scoop: Adamas' Gocovri Key Value Driver, BioMarin Data, Regeneron Q4 Results

2018-02-07T22:34:07-05:00
Sonoma Pharmaceuticals' (SNOA) CEO James Schutz on Q3 2018 Results - Earnings Call Transcript

2018-02-07T20:32:53-05:00
Sonoma Pharmaceuticals, Inc. 2017 Q4 - Results - Earnings Call Slides

2018-02-07T16:08:29-05:00
Sonoma Pharmaceuticals misses by $0.11, beats on revenue

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

6.17

Shares Float (M)

2.89

% Held by Insiders

53.10

% Held by Institutions

19.60

Shares Short (K)

17

Shares Short Prior Month (K)

7

Stock Financials

EPS

EPS Est. Current Year

-2.670

EPS Est. Next Year

-1.920

EPS Est. Next Quarter

-0.630

Forward EPS

-1.811

Book Value (p.s.)

1.650

PEG Ratio

Profit Margin

-73.56

Operating Margin

-72.52

Return on Assets (ttm)

-52.3

Return on Equity (ttm)

-64.7

Qtrly Rev. Growth

44.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-12.09

Levered Free Cash Flow (M)

-6.96

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

2.33

P/S

4631725.50

P/CF

-1.97

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-06-27

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.